Condition

Neoplasm, Breast

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 14 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials14
Recruiting5
Common interventions25
Lead sponsors shown14
Advertisement

Clinical trials

14 shown
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544 · 2026-08-03
RECRUITING
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)NCT05465031 · 2024-04-17
RECRUITING
TCM Therapy Program Impact on Breast Cancer Patients' Vital EnergyNCT06337214 · 2024-03-13
RECRUITING
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal StudyNCT05851053 · 2022-09-01
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26
RECRUITING
Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening ProgramsNCT05512260 · 2023-03-01
WITHDRAWN
Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.NCT05507034 · 2022-10-04
UNKNOWN
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)NCT05392608 · 2022-06-02
ACTIVE_NOT_RECRUITING
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast CancerNCT05033769 · 2021-03-11
UNKNOWN
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer PatientsNCT04678544 · 2020-12-23
COMPLETED
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerNCT03756064 · 2019-08-01
UNKNOWN
9-ING-41 in Patients With Advanced CancersNCT03678883 · 2019-01-04
ACTIVE_NOT_RECRUITING
To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph NodesNCT03715686 · 2018-10-20
UNKNOWN
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinNCT03368196 · 2018-04-02
COMPLETED

Common interventions

Trial status mix

RECRUITING5
UNKNOWN4
ACTIVE_NOT_RECRUITING2
COMPLETED2
WITHDRAWN1

Phase mix

NA6
PHASE12
PHASE22
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.